CM
DERM

Crestline Management’s Dermira, Inc. DERM Stock Holding History

Crestline Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-106,593
Closed -$981K – 271
2018
Q2 		$981K Sell
106,593
-39,192
-27% -$365K 0.1% 196
2018
Q1 		$1.17M Buy
+145,785
New +$3.17M 0.14% 132
2017
Q3 		– Sell
-19,917
Closed -$580K – 193
2017
Q2 		$580K Buy
19,917
+1,737
+10% +$52.8K 0.08% 109
2017
Q1 		$620K Sell
18,180
-2,949
-14% -$95.1K 0.11% 79
2016
Q4 		$641K Buy
21,129
+1,488
+8% +$48K 0.16% 45
2016
Q3 		$664K Buy
+19,641
New +$633K 0.08% 126

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Crestline Management's DERM Position: Q3 2018 in Review

Crestline Management sold out of Dermira, Inc. (DERM) in Q3 2018, closing a stake of 106,593 shares — an estimated $981K sold.

Crestline Management first reported a position in DERM in Q3 2016 and held it in 6 quarters. The position peaked at $1.17M in Q1 2018. 105 funds tracked by Wall St. Rank hold DERM as of Q3 2018.

  • Crestline Management reported no remaining Dermira, Inc. position as of Q3 2018 after selling out during the quarter.
  • Crestline Management sold 106,593 Dermira, Inc. shares in Q3 2018, an estimated $981K.
  • Crestline Management first reported a position in Dermira, Inc. in Q3 2016 and held it in 6 quarters.
  • Crestline Management's Dermira, Inc. position peaked at $1.17M in Q1 2018.
  • 105 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2018.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.